Search for: "RISING PHARMACEUTICALS, INC."
Results 261 - 280
of 462
Sorted by Relevance
|
Sort by Date
16 Nov 2009, 4:51 am
(Class 99) United States US General Wisconsin judge vacates $ 1.26 billion judgment in default against PepsiCo (IPKat) (IP Factor) California Court of Appeal: Von Dutch tradename settlement gives rise to legal malpractice action and questionable mediation confidentiality decision: Michael Cassel v Superior Court of Los Angeles County (The IP ADR Blog) US Patent Reform Putting the USPTO to work for independent inventors (Director's Forum) (Inventive Step) (IP Asset… [read post]
14 Jul 2011, 11:22 am
©2011 Amaxx Risk Solutions, Inc. [read post]
5 Nov 2015, 6:00 am
Mylan Pharmaceuticals Inc. v. [read post]
23 Mar 2011, 3:58 pm
A survey by CT TyMetrix Inc. and The Corporate Executive Board, The Real Rate Report, culled through $4.1 billion invoiced by over 3,500 law firms and 90,000 individual billers in 51 metropolitan areas over three years (2007-2009) to companies ranging in size from 1-1,900+ attorneys, and in 16 industries, including energy, entertainment, finance, insurance, healthcare, manufacturing, pharmaceutical, retail and technology. [read post]
7 Apr 2020, 2:01 am
Kathleen Duffy is president and CEO of Duffy Group, Inc., which sources and recruits candidates in the United States, Canada, Mexico, Central America, Europe, and Asia. [read post]
16 Nov 2010, 8:10 am
(“Shionogi”), a Japanese pharmaceutical company, in acquiring Sciele. [read post]
20 Apr 2011, 12:00 am
In 1990, Burton and his wife, Sheila, started Join Hands ESL Inc. for youth in East St. [read post]
25 Mar 2010, 7:29 am
BioMarin Pharmaceutical, Inc. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
14 Oct 2007, 6:39 pm
Today, China represents not only a fast-growing source of revenue for many multinational companies, but also a rising source of profit. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]
5 May 2011, 4:46 pm
Author Robert Elliott, executive vice president, Amaxx Risks Solutions, Inc. has worked successfully for 20 years with many industries to reduce Workers Compensation costs, including airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality and manufacturing. [read post]
27 Jul 2012, 12:40 pm
“[A]s condemnable as [the] flouting of FDA regulations may be, the off-label promotion of a pharmaceutical product in violation of the FDCA simply does not give rise to fraud-based rights of action. [read post]
9 Nov 2015, 7:09 am
Wal-Mart Stores, Inc. v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
12 Aug 2011, 6:29 am
United Health Group, Inc., No. 10-2747, which similarly concluded that violations of the AKS can give rise to liability under the FCA. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
17 Sep 2009, 4:50 am
The reasoning of that decision, questionable in its own right, is not applicable to a scenario outside of the prescription pharmaceutical context and the rise of direct-to-consumer advertising. [read post]
The Federal Trade Commission and Department of Justice Report on Antitrust and Intellectual Property
23 Jul 2007, 10:28 pm
Unilateral Refusals to License Patents The report begins with an analysis of unilateral refusals to license patents, focusing on two conflicting appellate decisions, Image Technical Services, Inc. v. [read post]
